drugset / Trial / NCT02228811
A Study of DCC-2701 in Participants With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to investigate the safety of the investigational drug DCC-2701 and whether it will work to help people who have advanced solid tumors or cancer that has spread to other parts of the body.
Timeline
- Start
- 2014-06
- Primary completion
- 2017-11
- Completion
- 2018-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALTIRATINIB | Small molecule | — | Oral |